In this review, we discuss the molecular basis underlying the oncogenic potential of HIF2α in ccRCC by focusing on those pathways primarily controlled by HIF2α that are thought to influence the progression of these tumors. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.